Common questions about Efferalgan (FAQ)
Q: How does the 'effervescent' format of Efferalgan change how it works compared to a regular tablet?
The official product information explains that effervescent forms must be dissolved in water before consumption. This format is often noted to facilitate faster absorption of the medicine into the body compared to standard tablets. It is also described as an option for individuals who may have difficulty swallowing pills.
Q: Does Efferalgan cause drowsiness or make you feel sleepy?
According to regulatory documentation, the standard, single-ingredient Efferalgan (containing only paracetamol) is generally not associated with drowsiness or sleepiness. However, combination products that include ingredients like the opioid analgesic Codeine may list drowsiness or dizziness as a potential side effect.
Q: Are there different types of Efferalgan (e.g., Efferalgan Codeine), and what is the difference in their active ingredients?
Yes, the product range includes different formulations. Some Efferalgan products are combination medicines that pair the active ingredient, paracetamol, with other substances, such as Codeine. These combination forms are generally indicated for the treatment of more severe pain.
Q: Does the effervescent tablet contain a lot of sodium (salt)?
Official product information states clearly that Effervescent tablets contain sodium. Regulatory documents note that the sodium content must be taken into account by patients on a controlled sodium diet. The specific quantity is listed on the official label or product information leaflet.
Q: Is it normal to see bubbles or foam when dissolving the tablet?
Yes, it is normal to see bubbles or foam when preparing the medicine. The effervescent format is specifically designed to release gas when placed in water, ensuring the tablet dissolves completely. Regulatory instructions require full dissolution before the solution is consumed.
Q: Can Efferalgan be taken alongside ibuprofen or aspirin?
Regulatory sources indicate that the active ingredient in Efferalgan (paracetamol) is generally compatible with other over-the-counter painkillers that do not contain paracetamol themselves. This includes medications such as ibuprofen or aspirin.
Q: Does Efferalgan affect the results of certain medical lab tests?
Official regulatory documents note that the active ingredient may interfere with the results of certain medical laboratory tests. This interaction has been noted with tests that measure levels of uric acid and blood sugar (glycemia).
Q: Can the effervescent tablet be swallowed whole instead of dissolved?
No. Official preparation instructions strictly state that the effervescent tablets must be completely dissolved in water prior to use. Official instructions state the product is required to be dissolved completely.
Q: What happens if a person taking Efferalgan misses a scheduled dose?
Regulatory guidelines emphasize the importance of strictly adhering to the minimum dosing interval and the maximum total daily dose. Regulatory guidelines note that taking a double dose is prohibited because it would violate the required minimum dosing interval.
Q: Is there any information about long-term use and potential cardiovascular side effects of the active ingredient in Efferalgan?
Official adverse event reports list some cardiovascular effects (e.g., hypotension, hypertension, tachycardia, peripheral edema). Regulatory documents, however, do not provide specific long-term cardiovascular risk statements related to chronic use.
Q: What is the difference between Efferalgan and the Efferalgan marketed for cough and cold?
Standard Efferalgan is a single-ingredient medicine that contains only Paracetamol. Products marketed for cough and cold symptoms are combination products that contain Paracetamol along with other medicines, such as a decongestant or cough suppressant.
Q: Can Efferalgan interact with herbal supplements?
Official guidance notes that there is limited regulatory information available to definitively confirm the safety of taking all complementary or herbal medicines at the same time as paracetamol.
Q: What are the typical symptoms of taking too much Efferalgan (overdose)?
According to regulatory documents, early symptoms of overdose (within the first 24 hours) may include nausea, vomiting, sweating, and feeling generally unwell. The most severe risk, acute liver damage, may not become clinically apparent until two to three days after the overdose.
Q: Why is Efferalgan often recommended as a first-line pain reliever?
The active ingredient in Efferalgan is recognized globally by major medical bodies (such as the WHO) as a foundational non-opioid analgesic. It is often noted as the first step in a structured approach for managing mild-to-moderate pain.
Q: Does the combination of paracetamol and codeine in some Efferalgan products pose a risk of dependence?
Yes, official regulatory warnings for Efferalgan products containing Codeine state that these medications are categorized as an opioid analgesic. As such, they carry a potential risk of causing both physical and psychological dependence.
Q: What are the contraindications listed for Efferalgan Codeine specifically?
Combination products containing Codeine have additional contraindications beyond the single-ingredient Efferalgan. These specific restrictions include use in individuals known to be ultra-rapid metabolizers of a certain enzyme (CYP2D6) and typically prohibit use in children following procedures like tonsillectomy.
Q: Does Efferalgan affect blood pressure or heart rate?
Official adverse event reports list both a decrease (hypotension) and an increase (hypertension) in blood pressure, as well as a rapid heart rate (tachycardia), as effects that have been noted in adverse event reports.
